Improving patient access to novel medical technologies in Europe

European Heart Journal

Volumn 27, Issue 7, 2006, Pages 882-885

  Kearney, Peter ^a   Stokoe, Graham ^b   Breithardt, Günter ^c   Longson, Carole ^d   Marco, Jean ^e   Morgan, John ^f   Priori, Silvia ^g   Ruether, Alric ^h   Taylor, Rod ⁱ   Hertog, Michaël ^j  

^a Department of Medicine National University of Ireland Cork   (Ireland)

^b Guidant Europe ^*  (Belgium)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

^e CLINIQUE PASTEUR   (France)

^f UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^g IRCCS   (Italy)

^h German Institute of Medical Documentation and Information   (Germany)

ⁱ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^j European Society of Cardiology (ESC)   (France)

more..

Author keywords

DES; Drug eluting stents; ESC guidelines; Funding; Health economics; Health technology assessment; ICD; Implantable cardioverter defibrillators

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOLOGIST; CONFERENCE PAPER; COST; DEFIBRILLATOR; DRUG ELUTING STENT; EUROPE; GERMANY; HEALTH CARE; HEALTH CARE COST; HEALTH ECONOMICS; HEART FAILURE; HUMAN; IMPLANT; MEDICAL TECHNOLOGY; PATIENT RIGHT; PHYSICIAN; PORTUGAL; PRIORITY JOURNAL; UNITED KINGDOM;

DEFIBRILLATORS, IMPLANTABLE; EUROPE; HEALTH SERVICES ACCESSIBILITY; HUMANS; PRACTICE GUIDELINES; STENTS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TECHNOLOGY, MEDICAL;

EID: 33645018513     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi794     Document Type: Conference Paper

References (5)

1. Priori SG, Klein W, Bassand, J-P. Medical Practice Guidelines: Separating science from economics. Eur Heart J 2003;24:1962-1964.
2. Taylor R. Pharmaceutical regulation: the early experience of the NHS National Institute for Clinical Excellence (NICE) appraisal process - where are we headed? Value Health 2001;4:8-11.
3. Nichol G, Kaul P, Huszti E, Bridgs JFP. Cost-efectiveness of cardiac resynchronizationn therapy in patients with symptomatic heart failure. Ann Intern Med 2004;141:343-351.
4. Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR. Cost effectiveness of cardiac resynchronization therapy in the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) trial. J Am Coll Cardiol 2005; 46:2311-2321.
5. Calvert MJ, Freemantle N, Yao G, Cleland JG, Billingham L, Daubert JC, Bryan S. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J 2005;26:2681-2688.